Isoniazid (INH) daily for 9 months

DRUG2 trials

Sponsors

Centers for Disease Control and Prevention, Taichung Veterans General Hospital

Conditions

Latent Tuberculosis InfectionTuberculosis

Phase 3

Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection

CompletedNCT00023452

Centers for Disease Control and PreventionTuberculosis

Start: 2001-06-30End: 2013-09-30Updated: 2024-08-27

Phase 4

Latent Tuberculosis in Type 2 Diabetes

Active, not recruitingNCT06874725

Taichung Veterans General HospitalLatent Tuberculosis Infection

Start: 2018-04-18End: 2025-04-18Updated: 2025-03-13

Related Papers

Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection

The Journal of Infectious Diseases2024-04-191 citations

Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials

Annals of the American Thoracic Society2018-02-0258 citations

Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada

Clinical Infectious Diseases2016-03-0646 citations

Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study

Clinical Infectious Diseases2015-04-22104 citations

Treatment for Preventing Tuberculosis in Children and Adolescents

JAMA Pediatrics2015-01-12218 citations

Three months of rifapentine and isoniazid for latent tuberculosis infection.

2011-12-01644 citations